ライソ酵素との複合体におけるサメ単一ドメイン抗体V領域の結晶構造
Robyn L Stanfield1, Helen Dooley, Martin F Flajnik
1Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
まとめ
軟骨魚は,適応免疫のためのユニークな新しい抗原受容体 (IgNARs) を持っている. 単一ドメインのIgNAR変数領域は,従来の抗体と同様に,高い親和性を持つ抗原を結合します.
科学分野:
- 免疫学 免疫学とは
- 構造生物学 構造生物学とは
- 進化生物学の進化生物学について
背景:
- 軟骨魚は,適応免疫を持つ古代の脊椎動物を表しています.
- 新しい抗原受容体 (IgNARs) は,これらの魚に特有の重鎖ホモジメロ免疫グロブリンです.
- IgNAR変数 (V) ドメインは,単一の免疫グロブリンドメインを使用して抗原を認識します.
研究 の 目的:
- IgNAR Vドメインによる抗原認識の構造的基礎を解明する.
- IgNAR Vドメイン構造と従来の抗体との結合インターフェースを比較する.
主な方法:
- 1.45アングストームの解像度のX線結晶学.
- I型IgNAR Vドメインと鶏卵白のリゾーシム (HEL) の間の複合形成.
主要な成果:
- HELに結合したIgnar Vドメインの結晶構造を決定した.
- IgNAR Vドメインは最小の抗原結合単位であり,従来の補完性を決定する領域が1つ欠けています.
- その単純さにもかかわらず,Ignar VドメインはHEL.ELに対するナノモラー親和性を表しています.
- 結合インターフェースのサイズは,従来の抗体と比較できます.
結論:
- IgNAR Vドメインは,軟骨魚における簡素化されながらも有効な抗原結合モジュールである.
- この構造は,抗体ドメインの進化と抗原認識の洞察を提供します.
さらに関連する動画
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
Published on: September 17, 2019
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
関連する概念動画
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Conservation of Protein Domains Over Different Proteins
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
